Analysts Issue Forecasts for Quipt Home Medical Corp.’s FY2021 Earnings (CVE:QIP)

Quipt Home Medical Corp. (CVE:QIP) – Analysts at Raymond James reduced their FY2021 earnings estimates for Quipt Home Medical in a research note issued to investors on Tuesday, November 23rd. Raymond James analyst R. Sarugaser now forecasts that the company will post earnings of ($0.21) per share for the year, down from their previous estimate of ($0.19). Raymond James also issued estimates for Quipt Home Medical’s Q1 2022 earnings at $0.04 EPS, Q2 2022 earnings at $0.08 EPS, FY2022 earnings at $0.40 EPS, FY2024 earnings at $1.60 EPS and FY2025 earnings at $2.29 EPS.

Separately, Echelon Wealth Partners reissued a “buy” rating on shares of Quipt Home Medical in a report on Tuesday, October 5th.

Quipt Home Medical (CVE:QIP) last released its earnings results on Monday, August 23rd. The company reported C$0.02 EPS for the quarter, missing the Thomson Reuters’ consensus estimate of C$0.03 by C($0.01). The business had revenue of C$32.24 million during the quarter, compared to analysts’ expectations of C$32.97 million.

Featured Story: Growth and Income Funds

Earnings History and Estimates for Quipt Home Medical (CVE:QIP)

Receive News & Ratings for Quipt Home Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quipt Home Medical and related companies with's FREE daily email newsletter.